The bill establishes comprehensive regulations for the sale and distribution of hemp-derived cannabinoid products in Kansas, defining key terms such as "approved source," "child-resistant," and "hemp-derived cannabinoid product." It mandates that all products sold in retail must originate from an approved source, be properly packaged and labeled, and have a valid certificate of analysis available upon request. The legislation prohibits sales to individuals under 21 and requires specific labeling, including product information and a tamper-evident seal. Additionally, packaging is restricted from using cartoon images or branding that may appeal to children. The bill also amends existing laws related to industrial hemp, clarifying definitions and establishing penalties for violations, while ensuring that products meet safety standards for dietary supplements, foods, and cosmetics.

Moreover, the bill revises definitions related to controlled substances, including terms like "immediate precursor," "manufacture," and "marijuana," with the latter now excluding certain parts of the Cannabis plant and FDA-approved products. New terms such as "electronic prescription," "electronic signature," and "facsimile transmission" are introduced to modernize the prescription process, emphasizing electronic transmission's role. The bill also defines "readily retrievable" and "ultimate user" in the context of controlled substances, and it repeals existing statutes K.S.A. 2-3908 and K.S.A. 2024 Supp. 2-3901, 21-5701, and 65-4101, indicating a significant update to the legal framework. The act will take effect upon publication in the statute book.

Statutes affected:
As introduced: 2-3901, 2-3908, 21-5701, 65-4101